FISH in Burkitt lymphoma diagnosis: a single Romanian center experience

1. Leoncini L, Raphael M, Stein H, Harris NL, Jaffe ES, Kluin PM. Burkitt Lymphoma. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. World Health Organisation Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. IARC Lyon. 2008: 262-264.Search in Google Scholar

2. Wright DH, Leong AS-Y, Addis JB. Burkitt Lymphoma/ Leukemia. Joanna Koster. Diagnostic lymph node pathology. Hodder Arnold. G London. 2006: 86-90Search in Google Scholar

3. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. Semin Cancer Biol. 2006 Aug;16(4):253-64.10.1016/j.semcancer.2006.07.01416904903Search in Google Scholar

4. Delsol G. Molecular abnormalities in lymphomas. Bull Cancer. 2010 Nov;97(11):1347-64.10.1684/bdc.2010.121421084243Search in Google Scholar

5. Roberti A, Rizzolio F, Lucchetti C, de Leval L, Giordano A, Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt lymphoma cell lines. Cell Cycle. 2011 Jan 1;10(1):127-34.10.4161/cc.10.1.1444621200153Search in Google Scholar

6. Reichard KK, Hall BK, Corn A, Foucar MK, Hozier J. Automated analysis of fluorescence in situ hybridization on fixed, paraffin-embedded whole tissue sections in Bcell lymphoma Mod Pathol. 2006 Aug;19(8):1027-33.10.1038/modpathol.380063016680153Search in Google Scholar

7. Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321-5.10.1038/ng.2468367456123143597Search in Google Scholar

8. Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, et al Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma. PLoS One. 2010 Sep 24;5(9).10.1371/journal.pone.0012960294576920930934Search in Google Scholar

9. Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P, Bellan C, et al. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA J Pathol. 2008 Dec;216(4):440-50.10.1002/path.241018802929Search in Google Scholar

10. Onnis A, Navari M, Antonicelli G, Morettini F, Mannucci S, De Falco G, et al. Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma. Blood Cancer J. 2012 Aug 31;2:e84.10.1038/bcj.2012.29343248422941339Search in Google Scholar

11. Dobrea C, Al Salamat H , Lupu AR. Diffuse large Bcell lymphoma - a new look and old prognostic factors. Rev Rom Med Lab, 2012 Dec 20(4): 307-315.Search in Google Scholar

12. Snuderl M, Kolman OK, Chen Y-B, Hsu JJ, Ackerman AM, Dal Cin P, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol. 2010 Mar;34(3):327-40.10.1097/PAS.0b013e3181cd3aeb315221220118770Search in Google Scholar

13. Naresh KN, Ibrahim HA, Lazzi S, Rince P, Onorati M, Ambrosio MR, et al. Diagnosis of Burkitt lymphoma using an algorithmic approach - applicable in both resource- poor and resource-rich countries. Br J Haematol. 2011 Jul 1. 154:770-776.10.1111/j.1365-2141.2011.08771.x21718280Search in Google Scholar

14. Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, et al. Double-hit Bcell lymphomas. Blood. 2011 Feb 24;117(8):2319-31.10.1182/blood-2010-09-29787921119107Search in Google Scholar

15. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011 May 12;117(19):5019-32. 10.1182/blood-2011-01-293050310952921300984Search in Google Scholar